comparemela.com

Latest Breaking News On - Fierce pharma asia - Page 1 : comparemela.com

Hengrui, Merck-Kelun, Dr Reddy s —Fierce Pharma Asia

Hengrui debuts global startup. Merck signs a potential $1.4 billion deal for a Chinese firm's cancer program. Dr. Reddy's sees growth in Russia.

Fierce pharma asiaJiangsu hengrui medicineMerck amp coDr reddy 039 sLuzsana biotechnologyAkebia therapeuticsAfseo vadadustatVrenzo roxadustatAnemia drugsBristol myers squibbBiologics plantLotte groupAlzheimer 039s diseaseShanghai green valley pharmaceuticalsAntifungal drugOhnson amp johnson

Fierce Pharma Asia—Takeda s patent cliff and rare disease setback; FDA s censure of Sun, Aurobindo

Takeda is preparing for the patent loss of its third-largest product but called it quits on a rare disease therapy.

Fierce pharma asiaSun pharmaceuticalAurobindo pharmaPatent lossesForm 483Alzheimer 039s diseaseJiangsu hengrui medicinePd 1 l1Merck kgaaTaiho pharmaceuticalFierce pharma homepage

Astellas, BeiGene, Serum Institute—Fierce Pharma Asia

Astellas takes gene therapy hit. Novartis and BeiGene post PD-1 win. Serum Institute halts COVID vaccine production.

Fierce pharma asiaCell amp gene therapyPd 1 l1Uchenne muscular dystrophy dmdSerum institute of indiaCovid 19Vaccine manufacturingPatent lawsuitsWuxi apptecFierce pharma homepage

Fierce Pharma Asia—Merck s former China head returns

Merck's former China head will return to the Big Pharma to lead international human health operations after a short stint at a Chinese company.

Fierce pharma asiaMerck amp coVaccine plantDepartment of defenseForm 483I mabIsk bioscienceCovid 19Asahi kaseiM amp aFierce pharma homepage

Fierce Pharma Asia—Legend CSO s departure; Takeda s gene therapy deal; Pfizer s India revamp

Legend Biotech's founding chief scientific officer has left the company without a new destination. Takeda has signed another gene therapy deal with Evozyne to work on protein sequences.

Fierce pharma asiaCell amp gene therapyLegend biotechDigital marketingHarbour biomedFierce pharma homepage

vimarsana © 2020. All Rights Reserved.